Real-time enrollment status for this chronic inducible urticaria clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 7:20 AM UTC
| NCT Number | NCT07540910 |
| Recruiting Status | Recruiting |
| Condition | Chronic Inducible Urticaria |
| Phase | PHASE1 |
| Target Enrollment | 98 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Enanta Pharmaceuticals, Inc |
| Last Updated on CT.gov | April 21, 2026 (Apr 21, 2026) |
As of August 30, 2026: Clinical trial NCT07540910 is currently recruiting participants. This phase1 study for chronic inducible urticaria is actively seeking new participants at 1 location across the United States. The study is sponsored by Enanta Pharmaceuticals, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07540910 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07540910 was last updated Apr 21, 2026 (April 21, 2026). HelloStudys verifies this status automatically.